Studies have demonstrated that key inflammatory markers, including C-reactive protein (CRP) and interleukins (ILs), are significantly elevated in individuals diagnosed with NAFLD and NASH (12). This evidence concerns the gene CRP and metabolic dysfunction-associated steatohepatitis.